Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Pharma marketing strategy

How Value-Based Messaging Improves Market Access
Posted in
  • Strategy & Execution

How Value-Based Messaging Improves Market Access

Market access has become one of the most critical challenges for pharmaceutical companies in today’s healthcare … How Value-Based Messaging Improves Market AccessRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Pharma Marketing Needs to Be Education-First
Posted in
  • Strategy & Execution
  • Uncategorized

Why Pharma Marketing Needs to Be Education-First

In today’s healthcare landscape, traditional marketing tactics focused solely on promotion no longer suffice. Patients, healthcare … Why Pharma Marketing Needs to Be Education-FirstRead more

by Jayshree Gondane•February 26, 2026February 26, 2026•0
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
Posted in
  • Industry Landscape
  • Strategy & Execution

How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market

In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•February 6, 2026February 6, 2026•0
Marketing Strategies for Companion Diagnostic Launches in the U.S. Pharmaceutical Market
Posted in
  • Digital Transformation
  • Strategy & Execution

Marketing Strategies for Companion Diagnostic Launches in the U.S. Pharmaceutical Market

Precision medicine has shifted from promise to expectation in the U.S. pharmaceutical market. For oncology, rare … Marketing Strategies for Companion Diagnostic Launches in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•January 1, 2026January 1, 2026•0

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A